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A Case of Anaphylaxis to Oral Minocycline
Minocycline is a semisynthetic tetracycline derivative that is often used in the treatment of 
acne vulgaris. To date, there has been only one case report of anaphylaxis to minocycline. 
We report here a case of anaphylaxis to oral minocycline. A 56-yr-old woman visited our 
hospital after three episodes of recurrent anaphylaxis. We performed an oral challenge test, 
the standard method for diagnosing drug allergies, with minocycline, one of the drugs she 
had taken previously. She developed urticaria, angioedema, nausea, vomiting, hypotension, 
and dyspnea within 4 min and was treated with intramuscular epinephrine, intravenous 
antihistamine and systemic corticosteroid. However, she presented similar symptoms at 50 
min and at 110 min. In prescribing oral minocycline, physicians should consider the 
possibility of serious adverse reactions, such as anaphylaxis.
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CASE REPORT
Immunology, Allergic Disorders & Rheumatology
INTRODUCTION
Allergic reactions to antibiotics are associated with increased 
rates of morbidity and mortality, as well as increased medical 
costs (1-3). Anaphylaxis is a life-threatening reaction to drugs. 
Although many cases of anaphylaxis to penicillin and cephalo-
sporin have been reported, anaphylaxis to tetracycline (4) is less 
common. Tetracycline is a broad-spectrum polyketide antibiotic 
produced by the Streptomyces genus of Actinobacteria, which 
has been indicated in the treatment of many types of bacterial 
infections. Although the use of tetracycline has decreased, mi-
nocycline, a semisynthetic, second-generation tetracycline de-
rivative, is still used worldwide in the treatment of acne. 
  Although minocycline is relatively safe, it has been reported 
to have adverse effects in 13.6% of treated patients (5). Common 
adverse effects of minocycline include gastrointestinal distur-
bances (nausea and vomiting), vestibular disturbance (dizzi-
ness), and cutaneous symptoms (hyperpigmentation of skin 
and mucous membranes, pruritis, urticaria, and photosensitive 
rash). Serious but rare adverse effects of minocycline include 
pneumonitis, hepatitis, pancreatitis, nephritis, polyarthritis, se-
rum sickness-like reaction, drug-induced lupus erythematosus-
like eruption, and hypersensitivity syndrome (6, 7).
  To our knowledge, only one case of anaphylaxis to oral mino-
cycline has been reported to date (8). Here we report a case of 
anaphylaxis to oral minocycline, confirmed by an oral challenge 
test.
CASE REPORT
A 56-yr-old woman visited our hospital after experiencing three 
episodes of recurrent anaphylaxis during the previous year. In 
every episode, she presented with urticaria, angioedema, dys-
pnea, and hypotension and visited the emergency department. 
In the first episode, she had generalized skin rash with an itch-
ing sensation, periorbital and perioral swelling, dyspnea, and 
dizziness. Her blood pressure decreased to 73/46 mmHg and 
she was diagnosed with and treated for anaphylaxis. At that time, 
the precipitating cause was not evaluated. During the second 
and third episodes, however, she noticed that her symptoms 
developed within a few minutes after taking bepotastine besi-
late, methylprednisolone, and minocycline for acne. 
  Her initial laboratory tests at the first visit to our hospital re-
vealed no apparent abnormalities except for mild leukocytosis 
(16,700/µL). Her total serum IgE concentration was 223 KU/L. 
Chest radiograph and electrocardiography were normal. Skin 
prick tests with inhalants and food allergens all showed nega-
tive results.
  We performed an oral minocycline challenge test to confirm 
the causative drug of her recurrent anaphylaxis. The patient took 
a half capsule of Minocin [50 mg]
® (SK Chemical Life Science, 
Seoul, Korea). Within 4 min, she began to feel an itching and 
burning sensation in her face and forearms, followed by the de-
velopment of generalized wheal. She also presented with peri-
orbital and lip swelling (Fig. 1). In 10 min she developed throat Jang JW, et al.  •  A Case of Anaphylaxis to Oral Minocycline
DOI: 10.3346/jkms.2010.25.8.1231 1232   http://jkms.org
discomfort, dyspnea and wheezing. She was distressed because 
of nausea, vomiting and dizziness. On physical examination, we 
heard a wheezing sound in her whole lung field and an abrupt 
fall in blood pressure, to 70/50 mmHg. At that time, her pulse 
rate was 55 beats/min, her respiratory rate was 24/min, and her 
SpO2 was 93%. She was administered two 0.3 cc doses of epi-
nephrine intramuscularly 5-min apart, along with intravenous 
chlorpheniramine (H1-antagonist) 4 mg, famotidine (H2-antag-
onist) 20 mg and hydrocortisone 250 mg. The patient also in-
haled an albuterol nebulizer (short-acting B2-agonist). Ten min-
utes later, her blood pressure had increased to 105/70 mmHg. 
Thirty minutes later, however, she again developed hypotension 
(80/40 mmHg), for which she was treated with additional intra-
muscular epinephrine. After 1 hr, she again developed hypoten-
sion (80/40 mmHg) (Fig. 2), for which she was managed with 
the same regimen. On the following day, the patient had fully 
recovered without apparent complications and discharged. She 
was educated about avoidance of tetracycline and given a ‘drug-
alert card’ . Since stopping minocycline, she has experienced no 
additional episodes of anaphylaxis.
DISCUSSION
Anaphylaxis is a rare, but serious, form of drug hypersensitivity.  
It is a systemic reaction mediated by vasoactive amines released 
from mast cells and basophils sensitized by immunoglobulin E 
(IgE). Immediate hypersensitivity reactions commonly involve 
at least two of the following major organ systems: cutaneous 
(generalized hives, pruritus, swollen lips-tongue-uvula), car-
diovascular (hypotension), respiratory (dyspnea due to laryn-
geal edema, bronchospasm, stridor), and gastrointestinal (vom-
iting, diarrhea, abdominal cramps) (9). Individuals differ in the 
time of appearance of symptoms and signs, but the hallmark of 
an anaphylactic reaction is the onset of some manifestations 
within seconds to minutes after introduction of the antigen. 
  Several reports have described anaphylactoid reactions to 
tetracycline (4), doxycycline (10), and oral minocycline (8). In 
the latter report, a 27-yr-old woman diagnosed with salpingitis 
and treated with 100-mg oral minocycline developed general-
ized wheal and erythema, dyspnea, and hypotension within 30 
min after taking minocycline. The symptoms cleared in about  
4 hr, and a scratch test performed on her forearm with minocy-
cline resulted in a positive reaction. In that case, however, an 
oral challenge test was not performed. 
  The pathogenesis of minocycline-induced hypersensitivity is 
unknown. These types of hypersensitivity reactions are thought 
to be caused by a reactive metabolite of a drug, which can bind 
to tissue macromolecules, causing cell damage, or can act as a 
hapten, eliciting an immune response. Although it is not known 
whether minocycline produces a reactive metabolite, it may 
generate an iminoquinone derivative. Neither tetracycline nor 
doxycycline contains the amino acid side chain that has the po-
tential to form a reactive intermediate, and therefore the hyper-
sensitivity associated with minocycline may be specific to this 
antibiotic. Further evaluation of the pathogenesis associated 
with minocycline is required (11).
  To our knowledge, this is the first case report to describe ana-
phylaxis to oral minocycline in Korea. The immediate and typi-
cal anaphylactic symptoms and signs, the dramatic triphasic 
reactions after oral challenge, and the previous history of ana-
phylaxis after exposure to minocycline, indicate that anaphy-
laxis in this patient was mediated by type I hypersensitivity re-
actions. To our knowledge, this report is also the first to utilize 
an oral challenge test, the standard method for the diagnosis of 
drug allergies, to confirm that minocycline was the culprit drug.
  Since minocycline remains a useful drug for the treatment of 
acne vulgaris, physicians should keep in mind that minocycline 
can induce anaphylaxis. In addition, this drug should be con-
sidered a causative agent in patients developing allergic reac-
tions. 
Fig. 1. Development of periorbital and perioral angioedema within 4 min after taking 
oral minocycline.
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Fig. 2. Changes in blood pressure following an oral minocycline challenge test. 
Arrows indicate times at which drugs were administered, including epinephrine, 
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